Zomedica Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Zomedica.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Zomedica.

Recommendation Trends

Rating	Jan '23
Strong Buy	0
Buy	0
Hold	0
Sell	0
Strong Sell	0
Total	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert Dawson James	Dawson James	Strong Buy Initiates $6	Strong Buy	Initiates	$6	+4,587.50%	Jan 6, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

27.78M

from 25.19M

10.28%

from 25.19M

Revenue Next Year

35.55M

from 27.78M

28.00%

from 27.78M

EPS This Year

-0.01

from -0.04

EPS Next Year

n/a

from -0.01

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	4.13M	18.93M	25.19M	27.78M	35.55M	45.78M
Revenue Growth	-	-	-	358.02%	33.05%	10.28%	28.00%	28.78%
EPS	-0.19	-0.05	-0.05	-0.02	-0.04	-0.01	-	-
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	2	2	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	28.9M	37.0M	47.6M
Avg	27.8M	35.6M	45.8M
Low	27.0M	34.5M	44.4M

Revenue Growth

Revenue Growth	2024	2025	2026
High	14.6%	33.1%	33.9%
Avg	10.3%	28.0%	28.8%
Low	7.0%	24.2%	25.0%

EPS Forecast

EPS	2024	2025	2026
High	-0.01	-	-
Avg	-0.01	-	-
Low	-0.01	-	-

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.